Tag: biomedical
-
Infographic – Digital Health Funding Continues Slide
Venture funding for digital health start-ups continued heading down in the third quarter of 2023, reaching low levels not seen in almost a decade.
-
Peanut Allergy Toothpaste Shown Safe in Trial
Results of a clinical trial show a peanut allergy treatment formulated as a toothpaste can safely deliver immunotherapy to raise recipients’ peanut tolerance.
-
Challenge Seeks Transformative Human/A.I. Research Tech
A new challenge competition with $1 million in prizes seeks novel techniques for conducting biomedical research with data on human physiology and artificial intelligence.
-
Life Science Incubator Gains $100M in Start-Up Funds
A new-business accelerator program, begun earlier this year to advance and commercialize biomedical research discoveries from academic labs, is receiving a $100 million founding grant.
-
Home V.R. Therapy Shown to Reduce Back Pain
A virtual reality program conducted at home is shown in a clinical trial to relieve chronic lower back pain intensity and improve daily living more than a sham V.R. program.
-
Electric Pulses Induce Lung Cancer Immune Response
Results of a clinical trial show a lung cancer therapy using highly focused pulses with electrical energy show signs of immune responses that can treat the patients’ tumors.
-
Merger to Form Programmable Nano-Medicines Company
A life science venture investor is merging two of its biotechnology portfolio companies to form a single developer of nanoscale medications with programmable properties.
-
Coalition to Boost African Ancestry Genomic Data
An historically Black medical college and pharmaceutical industry group began a program to increase the numbers of people of African descent in genomic databases.
-
Organ Chip Devices to Model for Radiation Sickness
The U.S. government’s health preparedness agency awarded a contract with a university lab to explore organ models on chips to document effects of radiation sickness.
-
Start-Up Adapts Crispr for Molecular Detection, Raises $40M
A new company is underway that says it adapts the gene editing technique Crispr to make detecting nucleic acid targets like DNA or RNA faster and simpler.